Phase 1 Study of Ripretinib, a Broad-Spectrum KIT and PDGFRA Inhibitor, in Patients with KIT-Mutated or KIT-Amplified Melanoma
Ripretinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 1 Study of Ripretinib, a Broad-Spectrum KIT and PDGFRA Inhibitor, in Patients with KIT-Mutated or KIT-Amplified Melanoma ### Output: Ripretinib